MX9101873A - Derivados de bencimidazol e imidazoles substituidos con bencimidazol e indol y composiciones farmaceuticas que los contienen - Google Patents
Derivados de bencimidazol e imidazoles substituidos con bencimidazol e indol y composiciones farmaceuticas que los contienenInfo
- Publication number
- MX9101873A MX9101873A MX9101873A MX9101873A MX9101873A MX 9101873 A MX9101873 A MX 9101873A MX 9101873 A MX9101873 A MX 9101873A MX 9101873 A MX9101873 A MX 9101873A MX 9101873 A MX9101873 A MX 9101873A
- Authority
- MX
- Mexico
- Prior art keywords
- bencimidazole
- indol
- derivatives
- contain
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60663190A | 1990-10-31 | 1990-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9101873A true MX9101873A (es) | 1992-06-05 |
Family
ID=24428787
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9101873A MX9101873A (es) | 1990-10-31 | 1991-10-31 | Derivados de bencimidazol e imidazoles substituidos con bencimidazol e indol y composiciones farmaceuticas que los contienen |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0488532A1 (es) |
| JP (1) | JPH0592969A (es) |
| KR (1) | KR920008032A (es) |
| CN (1) | CN1061224A (es) |
| AU (1) | AU650294B2 (es) |
| CA (1) | CA2054594A1 (es) |
| CS (1) | CS330591A3 (es) |
| EG (1) | EG19826A (es) |
| FI (1) | FI915148A (es) |
| HU (1) | HU214575B (es) |
| IE (1) | IE913785A1 (es) |
| IL (1) | IL99917A0 (es) |
| MX (1) | MX9101873A (es) |
| MY (1) | MY108611A (es) |
| NO (1) | NO180749C (es) |
| NZ (1) | NZ240383A (es) |
| PH (1) | PH31175A (es) |
| PL (1) | PL168902B1 (es) |
| PT (1) | PT99404A (es) |
| RO (1) | RO109735B1 (es) |
| RU (1) | RU2111208C1 (es) |
| YU (1) | YU173791A (es) |
| ZA (1) | ZA918688B (es) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT95899A (pt) * | 1989-11-17 | 1991-09-13 | Glaxo Group Ltd | Processo para a preparacao de derivados indole |
| GB9113628D0 (en) * | 1991-06-25 | 1991-08-14 | Ici Plc | Heterocyclic derivatives |
| GB9113626D0 (en) * | 1991-06-25 | 1991-08-14 | Ici Plc | Heterocyclic compounds |
| EP0602246A4 (en) * | 1992-03-25 | 1995-07-05 | Green Cross Corp | ISOINDAZOLE COMPOUND. |
| DK40192D0 (da) * | 1992-03-26 | 1992-03-26 | Neurosearch As | Imidazolforbindelser, deres fremstilling og anvendelse |
| CA2109931A1 (en) * | 1992-03-27 | 1993-10-14 | Hiroshi Matsui | Novel imidazole derivative, pharmaceutical use thereof, and intermediate therefor |
| US5538973A (en) * | 1992-03-27 | 1996-07-23 | Kyoto Pharmaceutical Industries, Ltd. | Imidazole derivative, pharmaceutical use thereof, and intermediate therefor |
| GB9218449D0 (en) | 1992-08-29 | 1992-10-14 | Boots Co Plc | Therapeutic agents |
| AU675484B2 (en) * | 1993-03-24 | 1997-02-06 | Neurosearch A/S | Benzimidazole compounds, their use and preparation |
| SE9903028D0 (sv) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
| KR20070028553A (ko) | 2004-06-18 | 2007-03-12 | 바이올리폭스 에이비 | 염증 치료에 유용한 인돌 |
| US8013006B2 (en) | 2004-07-14 | 2011-09-06 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US7868037B2 (en) | 2004-07-14 | 2011-01-11 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US7772271B2 (en) | 2004-07-14 | 2010-08-10 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| JP2008507518A (ja) | 2004-07-22 | 2008-03-13 | ピーティーシー セラピューティクス，インコーポレーテッド | Ｃ型肝炎を治療するためのチエノピリジン |
| KR20070114123A (ko) | 2005-01-19 | 2007-11-29 | 바이올리폭스 에이비 | 염증 치료에 유용한 인돌 |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| US7879802B2 (en) | 2007-06-04 | 2011-02-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| EP2321341B1 (en) | 2008-07-16 | 2017-02-22 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| CN103965167A (zh) * | 2013-01-29 | 2014-08-06 | 通化济达医药有限公司 | 咪唑羧酸衍生物 |
| EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| BR112015030326A2 (pt) | 2013-06-05 | 2017-08-29 | Synergy Pharmaceuticals Inc | Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos |
| CN106397414A (zh) * | 2015-08-14 | 2017-02-15 | 陈志龙 | 杂螺环酮吲哚衍生物的一种制备方法 |
| CN113999204B (zh) * | 2021-11-08 | 2023-09-05 | 常州大学 | 一种非手性咪唑型离子化合物及其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826862A (en) * | 1988-02-12 | 1989-05-02 | Janssen Pharmaceutica, N.V. | Anthelminthic [(5(6) (1H-azole-1-ylmethyl)benzimidazole]carbamates |
| GB8820231D0 (en) * | 1988-08-25 | 1988-09-28 | Fujisawa Pharmaceutical Co | New benzazole compounds processes for preparation thereof & pharmaceutical composition comprising same |
| PT95899A (pt) * | 1989-11-17 | 1991-09-13 | Glaxo Group Ltd | Processo para a preparacao de derivados indole |
| DE4010797A1 (de) * | 1990-04-04 | 1991-10-10 | Hoechst Ag | Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung |
-
1991
- 1991-10-23 PH PH43330A patent/PH31175A/en unknown
- 1991-10-29 NZ NZ240383A patent/NZ240383A/en unknown
- 1991-10-30 HU HU913418A patent/HU214575B/hu not_active IP Right Cessation
- 1991-10-30 EG EG66391A patent/EG19826A/xx active
- 1991-10-30 IE IE378591A patent/IE913785A1/en not_active Application Discontinuation
- 1991-10-30 NO NO914263A patent/NO180749C/no unknown
- 1991-10-30 RU SU5010095A patent/RU2111208C1/ru active
- 1991-10-30 RO RO148651A patent/RO109735B1/ro unknown
- 1991-10-31 JP JP3286584A patent/JPH0592969A/ja active Pending
- 1991-10-31 YU YU173791A patent/YU173791A/sh unknown
- 1991-10-31 MY MYPI9102106 patent/MY108611A/xx unknown
- 1991-10-31 IL IL99917A patent/IL99917A0/xx unknown
- 1991-10-31 AU AU86910/91A patent/AU650294B2/en not_active Ceased
- 1991-10-31 EP EP91310076A patent/EP0488532A1/en not_active Ceased
- 1991-10-31 MX MX9101873A patent/MX9101873A/es not_active IP Right Cessation
- 1991-10-31 CA CA002054594A patent/CA2054594A1/en not_active Abandoned
- 1991-10-31 CS CS913305A patent/CS330591A3/cs unknown
- 1991-10-31 PT PT99404A patent/PT99404A/pt not_active Application Discontinuation
- 1991-10-31 FI FI915148A patent/FI915148A/fi unknown
- 1991-10-31 ZA ZA918688A patent/ZA918688B/xx unknown
- 1991-10-31 KR KR1019910019254A patent/KR920008032A/ko active IP Right Grant
- 1991-10-31 PL PL91292249A patent/PL168902B1/pl unknown
- 1991-10-31 CN CN91110565A patent/CN1061224A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| RU2111208C1 (ru) | 1998-05-20 |
| AU650294B2 (en) | 1994-06-16 |
| JPH0592969A (ja) | 1993-04-16 |
| PH31175A (en) | 1998-03-20 |
| FI915148A (fi) | 1992-05-01 |
| MY108611A (en) | 1996-10-31 |
| PL168902B1 (pl) | 1996-05-31 |
| IE913785A1 (en) | 1992-05-22 |
| NO180749B (no) | 1997-03-03 |
| PL292249A1 (en) | 1992-07-13 |
| PT99404A (pt) | 1992-09-30 |
| HU214575B (hu) | 1998-04-28 |
| NO914263D0 (no) | 1991-10-30 |
| HUT59677A (en) | 1992-06-29 |
| IL99917A0 (en) | 1992-08-18 |
| EP0488532A1 (en) | 1992-06-03 |
| CA2054594A1 (en) | 1992-05-01 |
| ZA918688B (en) | 1992-08-26 |
| CN1061224A (zh) | 1992-05-20 |
| NZ240383A (en) | 1994-12-22 |
| EG19826A (en) | 1996-03-31 |
| CS330591A3 (en) | 1992-06-17 |
| RO109735B1 (ro) | 1995-05-30 |
| NO914263L (no) | 1992-05-04 |
| AU8691091A (en) | 1992-05-07 |
| YU173791A (sh) | 1994-01-20 |
| KR920008032A (ko) | 1992-05-27 |
| HU913418D0 (en) | 1992-01-28 |
| NO180749C (no) | 1997-06-11 |
| FI915148A0 (fi) | 1991-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9101873A (es) | Derivados de bencimidazol e imidazoles substituidos con bencimidazol e indol y composiciones farmaceuticas que los contienen | |
| MX9203576A (es) | Derivados de 3-amido pirazol y composiciones farmaceuticas que los contienen. | |
| MX9203027A (es) | Derivados heterociclicos de acilaminotiazoles y composicines farmaceuticas que los contienen. | |
| MX9202934A (es) | Derivados de carbostirilo y composicion farmaceutica que los contiene. | |
| MX9202545A (es) | Derivados biciclicos de rapamicina y composicion farmaceutica que los contiene. | |
| MX9203040A (es) | Derivados de quinona y composicion farmaceutica que los contiene. | |
| MX9203380A (es) | Derivados de carbazolil-(4)-oxi-propanolamina y composiciones farmaceuticas que los contienen. | |
| MX9203126A (es) | Derivados de sulfonilurea y composiciones farmaceuticas que los contienen. | |
| MX9202623A (es) | Compuestos de indol y composiciones farmaceuticas que los contienen. | |
| MX9205768A (es) | Derivados de 3-fenilpirazoles, procedimiento para su preparacion y composicion fungicida que los contiene | |
| MX9202910A (es) | Nuevos derivados de dihidropiridina y composicion farmaceutica que los contiene. | |
| MX9202546A (es) | Dimeros de rapamicina y composicion farmaceutica que los contiene. | |
| AR225458A1 (es) | Derivados de 1-(diclorofenil)-3-alquil-delta2-1,2,4-triazolin-5-ona y composiciones herbicidas que los contienen | |
| NO922683D0 (no) | Fremgangsmaate for hydrogenering av glyserol | |
| MX9204563A (es) | Nuevos derivados de la (2-alquil-3-piridil)-metilpiperazina y composicion farmaceutica que los comprende. | |
| MX26184A (es) | Derivados de benzopirano y analogos heterociclicosde los mismos. | |
| MX9202763A (es) | Nuevos derivados de 2-(1-piperazinil)-4-fenil-cicloalcanopiridina y composicion farmaceutica que los contiene. | |
| MX9206073A (es) | Nuevos compuestos antagonistas del receptor 5-hidroxitriptamina y composiciones farmaceuticas que los contienen | |
| MX9203613A (es) | Derivados de adenosina y composiciones farmaceuticas que los contienen. | |
| IT8848618A0 (it) | Derivati di lisogangliosidi | |
| MX9203383A (es) | Nuevos derivados de piridobenzoindol y composiciones farmaceuticas que los contienen. | |
| MX9203021A (es) | Derivados de carbostirilo y composicion farmaceutica que los contiene. | |
| MX9203732A (es) | R-enentiomeros de compuestos de n-propargil-1-aminoindan, su preparacion y composiciones farmaceuticas que contienen los mismos. | |
| MX9203632A (es) | Derivados de cicloalquiltiazol y composiciones farmaceuticas que los contienen. | |
| MX9203241A (es) | Derivados de indol y composiciones farmaceuticas que los contienen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| MM | Annulment or lapse due to non-payment of fees |